NIH 2006 R56 CA |
Validation of Genes That Modulate Doxorubicin Therapy Mousses, Spyro / Translational Genomics Research Institute |
$396,947 |
NIH 2005 R56 CA |
Validation of Genes That Modulate Doxorubicin Therapy Mousses, Spyro / Translational Genomics Research Institute |
$406,500 |